Humsa S Venkatesh

Title: Humsa S Venkatesh: Innovator in Glioma Treatment

Introduction

Humsa S Venkatesh is a notable inventor based in Milpitas, CA (US). He has made significant contributions to the field of medical science, particularly in the treatment of glioma, a type of brain tumor. His innovative approach has the potential to improve therapeutic outcomes for patients suffering from this challenging condition.

Latest Patents

Humsa S Venkatesh holds 1 patent for a method of treating glioma. This patent outlines methods that involve administering a therapeutically-effective amount of an agent that inhibits the activity of specific neuronal activity-regulated proteins, including neuroligin-3, brain-derived neurotrophic factor (BDNF), or brevican. The invention aims to treat neurological dysfunction, reduce the invasion of glioma cells into brain tissue, and decrease the growth rate of glioma in patients. Additionally, the patent includes methods for identifying agents that modulate the mitotic index of glial cells and for stimulating the proliferation of these cells. Kits for practicing these methods are also provided.

Career Highlights

Humsa S Venkatesh is affiliated with Leland Stanford Junior University, where he continues to advance research in the field of neuroscience and oncology. His work is characterized by a commitment to developing innovative solutions for complex medical challenges.

Collaborations

Humsa collaborates with Michelle Monje-Deisseroth, a fellow researcher in the field. Their partnership enhances the research efforts aimed at understanding and treating glioma more effectively.

Conclusion

Humsa S Venkatesh's contributions to glioma treatment exemplify the impact of innovative thinking in medical research. His patent and ongoing work at Leland Stanford Junior University highlight the importance of collaboration and dedication in advancing healthcare solutions.